Maternal serum inhibin levels in twin and singleton pregnancies conceived by assisted reproduction

Human Reproduction

Volumn 21, Issue 5, 2006, Pages 1305-1308

  Maymon, Ron ^a,c   Cuckle, Howard ^b   Herman, Arie ^a,c  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Antenatal screening; Assisted reproduction technology; Down's syndrome; Inhibin; Twins

Indexed keywords

INHIBIN;

ADULT; AMNIOCENTESIS; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DOWN SYNDROME; ECHOGRAPHY; FEMALE; FERTILIZATION IN VITRO; FETUS; FOLLOW UP; HUMAN; INFERTILITY THERAPY; ISRAEL; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL BLOOD; MEDICAL DECISION MAKING; OOCYTE DONATION; PATIENT MONITORING; PATIENT REFERRAL; PRENATAL DIAGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RANK SUM TEST; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY; THERAPEUTIC ABORTION; TWIN PREGNANCY; UNITED KINGDOM;

EID: 33645809347     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dei492     Document Type: Article

References (23)

1. Abbas A, Johnson M, Bersinger N and Nicolaides K (1994) Maternal alphafetoprotein levels in multiple pregnancies. Br J Obstet Gynaecol 101, 156-158.
2. Cuckle H (1998) Down's syndrome screening in twins. J Med Screen 5,3-4.
3. Cuckle H and Arbuzova S (2004) Multianalyte maternal serum screening for chromosomal defects. In Milunsky A (ed.) Genetic Disorders and the Fetus: Diagnosis, Prevention and Treatment, 5th edn. Johns Hopkins University Press, Baltimore, pp. 795-835.
4. Cuckle H, Benn P and Wright D (2005) Down syndrome screening in the first and/or second trimester: Model predicted performance using meta-analysis parameters. Semin Perinatol, 29,252-257.
5. Ferriman EL, Sehmi IK, Jones R and Cuckle HS (1999) The effect of smoking in pregnancy on maternal serum inhibin A levels. Prenat Diagn 19,372-374.
6. Grau P, Robinson L, Tabsh K and Crandall BF (1990) Elevated maternal serum alpha-fetoprotein and amniotic fluid alpha-fetoprotein after multifetal pregnancy reduction. Obstet Gynecol 76,1042-1045.
7. Groutz A, Amit A, Yaron Y, Yovel I, Wolman I, Legum C and Lessing JB (1996) Second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin and unconjugated oestriol after early transvaginal multifetal pregnancy reduction. Prenat Diagn 16,723-727.
8. Lynch L and Berkowitz RL (1993) Maternal serum alpha-fetoprotein and coagulation profiles after multifetal pregnancy reduction. Am J Obstet Gynecol 169,987-990.
9. Marrs RP, Kletzky OA, Howard WF and Mishel DR (1979) Disappearance of human chorionic gonadotropin and resumption of ovulation following abortion. Am J Obstet Gynecol 135,731-736.
10. Maymon R, Herman A, Shulman A, Halperin R, Arieli S, Bukovsky I and Weinraub Z (1995) First trimester embryo reduction: A medical solution to an introgenic problem. Hum Reprod 10,668-673.
11. Maymon R and Shulman A (2001) Comparison of triple serum screening and pregnancy outcome in oocyte donation versus IVF pregnancies. Hum Reprod 16,691-695.
12. Nyboe Andersen A, Gianaroli L and Nygren KG (2004) European IVF-monitoring programme; European Society of Human Reproduction and Embryology 2004 Assisted reproductive technology in Europe, 2000. Results generated from European registers by ESHRE. Hum Reprod 19,490-503.
13. Orlandi F, Rossi C, Allegra A, Krantz D, Hallahan T, Orlandi E and Macri J (2002) First trimester screening with free beta-hCG, PAPP-A and nuchal translucency in pregnancies conceived with assisted reproduction. Prenat Diagn 22,718-721.
14. Räty R, Virtanen A, Koskinen P, Laitinen P, Forsstrom J, Salonen R, Morsky P and Ekblad U (2000) Maternal midtrimester serum AFP and free beta-hCG levels in in vitro fertilization twin pregnancies. Prenat Diagn 20,221-223.
15. Renier MA, Vereecken A, Van Herck E, Straetmans D, Ramaekers P and Buytaert P (1998) Second trimester maternal dimeric inhibin-A in the multiple-marker screening test for Down's syndrome. Hum Reprod 13,744-748.
16. Ribbert LS, Kornman LH, DeWolf BT, Simons AH, Jansen CA, Beekhuis JR and Mantingh A (1996) Maternal serum screening for fetal Down syndrome in IVF pregnancies. Prenat Diagn 16,35-38.
17. Rotmensch S, Celentano C, Shalev J, Vishne TH, Lipitz S, Ben-Rafael Z and Glezerman M (1999) Midtrimester maternal serum screening after multifetal pregnancy reduction in pregnancies conceived by in vitro fertilization. J Assist Reprod Genet 16,8-12.
18. Rudnicka AR, Wald NJ, Huttly W and Hackshaw AK (2002) Influence of maternal smoking on the birth prevalence of Down syndrome and on second trimester screening performance. Prenat Diagn 22,893-897.
19. Shulman LP and Phillips OP (1997) Second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin and unconjugated oestriol after early transvaginal multifetal pregnancy reduction. Prenat Diagn 17,488-490.
20. Shulman LP, Phillips OP and Cervetti TA (1996) Maternal serum analyte levels after first-trimester multifetal pregnancy reduction. Am J Obstet Gynecol 174,1072-1074.
21. Spencer K and Nicolaides KH (2003) Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: A review of three years experience. Br J Obstet Gynaecol 110, 276-280.
22. Wald N, White N, Morris JK, Huttly WJ and Canick JA (1999) Serum markers for Down's syndrome in women who have had in vitro fertilisation: implications for antenatal screening. Br J Obstet Gynaecol 106,1304-1306.
23. Watt HC, Wald NJ and George L (1996) Maternal serum inhibin-A levels in twin pregnancies: Implications for screening for Down's syndrome. Prenat Diagn 16,927-929.